APO Research
Talk to an analyst

APO RESEARCH · REPORT

Compound Andrographis Paniculata Tablets

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Compound Andrographis Paniculata Tablets Industry Growth and Trends Forecast to 2032

26 December 2025129 pages

Choose your research edition.

Industry ResearchCompound Andrographis Paniculata Tablets Industry Research Report 2026146 pages · $2,950 USDIndustry Growth & TrendsGlobal Compound Andrographis Paniculata Tablets Industry Growth and Trends Forecast to 2032129 pages · $3,450 USDMarket StructureGlobal Compound Andrographis Paniculata Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Compound Andrographis Paniculata Tablets Market Outlook and Growth Opportunities 2026201 pages · $4,250 USDMarket Analysis & ForecastGlobal Compound Andrographis Paniculata Tablets Market Analysis and Forecast 2026-2032208 pages · $4,950 USD

Market perspective

The global Compound Andrographis Paniculata Tablets market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Compound Andrographis Paniculata Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Compound Andrographis Paniculata Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Compound Andrographis Paniculata Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Compound Andrographis Paniculata Tablets include Baotou Traditional Chinese Medicine Co., Ltd., Guangdong Hengcheng Pharmaceutical Co., Ltd., Guangdong Huazhou Traditional Chinese Medicine Factory Pharmaceutical Co., Ltd., Guangxi Beibu Gulf Pharmaceutical Co., Ltd., Guangxi Chanfang Pharmaceutical Co., Ltd., Guangxi Jinye Pharmaceutical Co., Ltd., Hefei Cube Pharmaceutical Co., Ltd., Henan Lingrui Pharmaceutical Co., Ltd. and Huizhou Daya Pharmaceutical Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Compound Andrographis Paniculata Tablets market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Compound Andrographis Paniculata Tablets market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Compound Andrographis Paniculata Tablets market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Compound Andrographis Paniculata Tablets.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Compound Andrographis Paniculata Tablets market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Compound Andrographis Paniculata Tablets Market by Company

Baotou Traditional Chinese Medicine Co., Ltd.

Guangdong Hengcheng Pharmaceutical Co., Ltd.

Guangdong Huazhou Traditional Chinese Medicine Factory Pharmaceutical Co., Ltd.

Guangxi Beibu Gulf Pharmaceutical Co., Ltd.

Guangxi Chanfang Pharmaceutical Co., Ltd.

Guangxi Jinye Pharmaceutical Co., Ltd.

Hefei Cube Pharmaceutical Co., Ltd.

Henan Lingrui Pharmaceutical Co., Ltd.

Huizhou Daya Pharmaceutical Co., Ltd.

Leshi Tongren Sanmenxia Pharmaceutical Co., Ltd.

Luoyang Homeopathic Pharmaceutical Co., Ltd.

Sanmenxia Guangyu Biopharmaceutical Co., Ltd.

Sichuan Everbright Pharmaceutical Co., Ltd.

Sichuan Senke Pharmaceutical Co., Ltd.

Sichuan Tianji Biopharmaceutical Co., Ltd.

Sichuan Tongyuan Pharmaceutical Group Co., Ltd.

Sichuan Tiande Pharmaceutical Co., Ltd.

Teyi Pharmaceutical Group Co., Ltd.

Yunnan Dai Medicine Co., Ltd.

Zhongshan Kekekang Pharmaceutical Co., Ltd.

Compound Andrographis Paniculata Tablets Segment by Type

Film-coated Tablets

Sugar-coated Tablets

Compound Andrographis Paniculata Tablets Segment by Application

Hospital

Clinic

Other

Compound Andrographis Paniculata Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Compound Andrographis Paniculata Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Compound Andrographis Paniculata Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Compound Andrographis Paniculata Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Compound Andrographis Paniculata Tablets manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Compound Andrographis Paniculata Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Film-coated Tablets Table 2. Major Company of Sugar-coated Tablets Table 3. Global Compound Andrographis Paniculata Tablets Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Compound Andrographis Paniculata Tablets Sales by Type (2021-2026) & (K Units) Table 5. Global Compound Andrographis Paniculata Tablets Sales Market Share in Volume by Type (2021-2026) Table 6. Global Compound Andrographis Paniculata Tablets Sales by Type (2021-2026) & (US$ Million) Table 7. Global Compound Andrographis Paniculata Tablets Sales Market Share in Value by Type (2021-2026) Table 8. Global Compound Andrographis Paniculata Tablets Price by Type (2021-2026) & (US$/Unit) Table 9. Global Compound Andrographis Paniculata Tablets Sales by Type (2027-2032) & (K Units) Table 10. Global Compound Andrographis Paniculata Tablets Sales Market Share in Volume by Type (2027-2032) Table 11. Global Compound Andrographis Paniculata Tablets Sales by Type (2027-2032) & (US$ Million) Table 12. Global Compound Andrographis Paniculata Tablets Sales Market Share in Value by Type (2027-2032) Table 13. Global Compound Andrographis Paniculata Tablets Price by Type (2027-2032) & (US$/Unit) Table 14. North America Compound Andrographis Paniculata Tablets Sales by Type (2021-2026) & (K Units) Table 15. North America Compound Andrographis Paniculata Tablets Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Compound Andrographis Paniculata Tablets Sales by Type (2021-2026) & (K Units) Table 17. Europe Compound Andrographis Paniculata Tablets Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Compound Andrographis Paniculata Tablets Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Compound Andrographis Paniculata Tablets Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Compound Andrographis Paniculata Tablets Sales by Type (2021-2026) & (K Units) Table 21. Latin America Compound Andrographis Paniculata Tablets Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Compound Andrographis Paniculata Tablets Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Compound Andrographis Paniculata Tablets Sales by Type (2021-2026) & (US$ Million) Table 24. Compound Andrographis Paniculata Tablets Industry Trends Table 25. Compound Andrographis Paniculata Tablets Industry Drivers Table 26. Compound Andrographis Paniculata Tablets Industry Opportunities and Challenges Table 27. Compound Andrographis Paniculata Tablets Industry Restraints Table 28. Global Compound Andrographis Paniculata Tablets Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Compound Andrographis Paniculata Tablets Revenue Market Share by Company (2021-2026) Table 30. Global Compound Andrographis Paniculata Tablets Sales by Company (2021-2026) & (K Units) Table 31. Global Compound Andrographis Paniculata Tablets Sales Share by Company (2021-2026) Table 32. Global Compound Andrographis Paniculata Tablets Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Compound Andrographis Paniculata Tablets Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Compound Andrographis Paniculata Tablets Major Company Production Sites and Headquarters Table 35. Global Compound Andrographis Paniculata Tablets Company, Product Type & Application Table 36. Global Compound Andrographis Paniculata Tablets Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Compound Andrographis Paniculata Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Compound Andrographis Paniculata Tablets Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Compound Andrographis Paniculata Tablets Sales by Region (2021-2026) & (K Units) Table 41. Global Compound Andrographis Paniculata Tablets Sales Market Share in Volume by Region (2021-2026) Table 42. Global Compound Andrographis Paniculata Tablets Sales by Region (2021-2026) & (US$ Million) Table 43. Global Compound Andrographis Paniculata Tablets Sales Market Share in Value by Region (2021-2026) Table 44. Global Compound Andrographis Paniculata Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Compound Andrographis Paniculata Tablets Sales by Region (2027-2032) & (K Units) Table 46. Global Compound Andrographis Paniculata Tablets Sales Market Share in Volume by Region (2027-2032) Table 47. Global Compound Andrographis Paniculata Tablets Sales by Region (2027-2032) & (US$ Million) Table 48. Global Compound Andrographis Paniculata Tablets Sales Market Share in Value by Region (2027-2032) Table 49. Global Compound Andrographis Paniculata Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Compound Andrographis Paniculata Tablets Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Compound Andrographis Paniculata Tablets Sales by Application (2021-2026) & (K Units) Table 52. Global Compound Andrographis Paniculata Tablets Sales Market Share in Volume by Application (2021-2026) Table 53. Global Compound Andrographis Paniculata Tablets Sales by Application (2021-2026) & (US$ Million) Table 54. Global Compound Andrographis Paniculata Tablets Sales Market Share in Value by Application (2021-2026) Table 55. Global Compound Andrographis Paniculata Tablets Price by Application (2021-2026) & (US$/Unit) Table 56. Global Compound Andrographis Paniculata Tablets Sales by Application (2027-2032) & (K Units) Table 57. Global Compound Andrographis Paniculata Tablets Sales Market Share in Volume by Application (2027-2032) Table 58. Global Compound Andrographis Paniculata Tablets Sales by Application (2027-2032) & (US$ Million) Table 59. Global Compound Andrographis Paniculata Tablets Sales Market Share in Value by Application (2027-2032) Table 60. Global Compound Andrographis Paniculata Tablets Price by Application (2027-2032) & (US$/Unit) Table 61. North America Compound Andrographis Paniculata Tablets Sales by Application (2021-2026) & (K Units) Table 62. North America Compound Andrographis Paniculata Tablets Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Compound Andrographis Paniculata Tablets Sales by Application (2021-2026) & (K Units) Table 64. Europe Compound Andrographis Paniculata Tablets Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Compound Andrographis Paniculata Tablets Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Compound Andrographis Paniculata Tablets Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Compound Andrographis Paniculata Tablets Sales by Application (2021-2026) & (K Units) Table 68. Latin America Compound Andrographis Paniculata Tablets Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Compound Andrographis Paniculata Tablets Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Compound Andrographis Paniculata Tablets Sales by Application (2021-2026) & (US$ Million) Table 71. Baotou Traditional Chinese Medicine Co., Ltd. Company Information Table 72. Baotou Traditional Chinese Medicine Co., Ltd. Business Overview Table 73. Baotou Traditional Chinese Medicine Co., Ltd. Compound Andrographis Paniculata Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Baotou Traditional Chinese Medicine Co., Ltd. Compound Andrographis Paniculata Tablets Product Portfolio Table 75. Baotou Traditional Chinese Medicine Co., Ltd. Recent Development Table 76. Guangdong Hengcheng Pharmaceutical Co., Ltd. Company Information Table 77. Guangdong Hengcheng Pharmaceutical Co., Ltd. Business Overview Table 78. Guangdong Hengcheng Pharmaceutical Co., Ltd. Compound Andrographis Paniculata Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Guangdong Hengcheng Pharmaceutical Co., Ltd. Compound Andrographis Paniculata Tablets Product Portfolio Table 80. Guangdong Hengcheng Pharmaceutical Co., Ltd. Recent Development Table 81. Guangdong Huazhou Traditional Chinese Medicine Factory Pharmaceutical Co., Ltd. Company Information Table 82. Guangdong Huazhou Traditional Chinese Medicine Factory Pharmaceutical Co., Ltd. Business Overview Table 83. Guangdong Huazhou Traditional Chinese Medicine Factory Pharmaceutical Co., Ltd. Compound Andrographis Paniculata Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Guangdong Huazhou Traditional Chinese Medicine Factory Pharmaceutical Co., Ltd. Compound Andrographis Paniculata Tablets Product Portfolio Table 85. Guangdong Huazhou Traditional Chinese Medicine Factory Pharmaceutical Co., Ltd. Recent Development Table 86. Guangxi Beibu Gulf Pharmaceutical Co., Ltd. Company Information Table 87. Guangxi Beibu Gulf Pharmaceutical Co., Ltd. Business Overview Table 88. Guangxi Beibu Gulf Pharmaceutical Co., Ltd. Compound Andrographis Paniculata Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Guangxi Beibu Gulf Pharmaceutical Co., Ltd. Compound Andrographis Paniculata Tablets Product Portfolio Table 90. Guangxi Beibu Gulf Pharmaceutical Co., Ltd. Recent Development Table 91. Guangxi Chanfang Pharmaceutical Co., Ltd. Company Information Table 92. Guangxi Chanfang Pharmaceutical Co., Ltd. Business Overview Table 93. Guangxi Chanfang Pharmaceutical Co., Ltd. Compound Andrographis Paniculata Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Guangxi Chanfang Pharmaceutical Co., Ltd. Compound Andrographis Paniculata Tablets Product Portfolio Table 95. Guangxi Chanfang Pharmaceutical Co., Ltd. Recent Development Table 96. Guangxi Jinye Pharmaceutical Co., Ltd. Company Information Table 97. Guangxi Jinye Pharmaceutical Co., Ltd. Business Overview Table 98. Guangxi Jinye Pharmaceutical Co., Ltd. Compound Andrographis Paniculata Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Guangxi Jinye Pharmaceutical Co., Ltd. Compound Andrographis Paniculata Tablets Product Portfolio Table 100. Guangxi Jinye Pharmaceutical Co., Ltd. Recent Development Table 101. Hefei Cube Pharmaceutical Co., Ltd. Company Information Table 102. Hefei Cube Pharmaceutical Co., Ltd. Business Overview Table 103. Hefei Cube Pharmaceutical Co., Ltd. Compound Andrographis Paniculata Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Hefei Cube Pharmaceutical Co., Ltd. Compound Andrographis Paniculata Tablets Product Portfolio Table 105. Hefei Cube Pharmaceutical Co., Ltd. Recent Development Table 106. Henan Lingrui Pharmaceutical Co., Ltd. Company Information Table 107. Henan Lingrui Pharmaceutical Co., Ltd. Business Overview Table 108. Henan Lingrui Pharmaceutical Co., Ltd. Compound Andrographis Paniculata Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Henan Lingrui Pharmaceutical Co., Ltd. Compound Andrographis Paniculata Tablets Product Portfolio Table 110. Henan Lingrui Pharmaceutical Co., Ltd. Recent Development Table 111. Huizhou Daya Pharmaceutical Co., Ltd. Company Information Table 112. Huizhou Daya Pharmaceutical Co., Ltd. Business Overview Table 113. Huizhou Daya Pharmaceutical Co., Ltd. Compound Andrographis Paniculata Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Huizhou Daya Pharmaceutical Co., Ltd. Compound Andrographis Paniculata Tablets Product Portfolio Table 115. Huizhou Daya Pharmaceutical Co., Ltd. Recent Development Table 116. Leshi Tongren Sanmenxia Pharmaceutical Co., Ltd. Company Information Table 117. Leshi Tongren Sanmenxia Pharmaceutical Co., Ltd. Business Overview Table 118. Leshi Tongren Sanmenxia Pharmaceutical Co., Ltd. Compound Andrographis Paniculata Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Leshi Tongren Sanmenxia Pharmaceutical Co., Ltd. Compound Andrographis Paniculata Tablets Product Portfolio Table 120. Leshi Tongren Sanmenxia Pharmaceutical Co., Ltd. Recent Development Table 121. Luoyang Homeopathic Pharmaceutical Co., Ltd. Company Information Table 122. Luoyang Homeopathic Pharmaceutical Co., Ltd. Business Overview Table 123. Luoyang Homeopathic Pharmaceutical Co., Ltd. Compound Andrographis Paniculata Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Luoyang Homeopathic Pharmaceutical Co., Ltd. Compound Andrographis Paniculata Tablets Product Portfolio Table 125. Luoyang Homeopathic Pharmaceutical Co., Ltd. Recent Development Table 126. Sanmenxia Guangyu Biopharmaceutical Co., Ltd. Company Information Table 127. Sanmenxia Guangyu Biopharmaceutical Co., Ltd. Business Overview Table 128. Sanmenxia Guangyu Biopharmaceutical Co., Ltd. Compound Andrographis Paniculata Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. Sanmenxia Guangyu Biopharmaceutical Co., Ltd. Compound Andrographis Paniculata Tablets Product Portfolio Table 130. Sanmenxia Guangyu Biopharmaceutical Co., Ltd. Recent Development Table 131. Sichuan Everbright Pharmaceutical Co., Ltd. Company Information Table 132. Sichuan Everbright Pharmaceutical Co., Ltd. Business Overview Table 133. Sichuan Everbright Pharmaceutical Co., Ltd. Compound Andrographis Paniculata Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 134. Sichuan Everbright Pharmaceutical Co., Ltd. Compound Andrographis Paniculata Tablets Product Portfolio Table 135. Sichuan Everbright Pharmaceutical Co., Ltd. Recent Development Table 136. Sichuan Senke Pharmaceutical Co., Ltd. Company Information Table 137. Sichuan Senke Pharmaceutical Co., Ltd. Business Overview Table 138. Sichuan Senke Pharmaceutical Co., Ltd. Compound Andrographis Paniculata Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 139. Sichuan Senke Pharmaceutical Co., Ltd. Compound Andrographis Paniculata Tablets Product Portfolio Table 140. Sichuan Senke Pharmaceutical Co., Ltd. Recent Development Table 141. Sichuan Tianji Biopharmaceutical Co., Ltd. Company Information Table 142. Sichuan Tianji Biopharmaceutical Co., Ltd. Business Overview Table 143. Sichuan Tianji Biopharmaceutical Co., Ltd. Compound Andrographis Paniculata Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 144. Sichuan Tianji Biopharmaceutical Co., Ltd. Compound Andrographis Paniculata Tablets Product Portfolio Table 145. Sichuan Tianji Biopharmaceutical Co., Ltd. Recent Development Table 146. Sichuan Tongyuan Pharmaceutical Group Co., Ltd. Company Information Table 147. Sichuan Tongyuan Pharmaceutical Group Co., Ltd. Business Overview Table 148. Sichuan Tongyuan Pharmaceutical Group Co., Ltd. Compound Andrographis Paniculata Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 149. Sichuan Tongyuan Pharmaceutical Group Co., Ltd. Compound Andrographis Paniculata Tablets Product Portfolio Table 150. Sichuan Tongyuan Pharmaceutical Group Co., Ltd. Recent Development Table 151. Sichuan Tiande Pharmaceutical Co., Ltd. Company Information Table 152. Sichuan Tiande Pharmaceutical Co., Ltd. Business Overview Table 153. Sichuan Tiande Pharmaceutical Co., Ltd. Compound Andrographis Paniculata Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 154. Sichuan Tiande Pharmaceutical Co., Ltd. Compound Andrographis Paniculata Tablets Product Portfolio Table 155. Sichuan Tiande Pharmaceutical Co., Ltd. Recent Development Table 156. Teyi Pharmaceutical Group Co., Ltd. Company Information Table 157. Teyi Pharmaceutical Group Co., Ltd. Business Overview Table 158. Teyi Pharmaceutical Group Co., Ltd. Compound Andrographis Paniculata Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 159. Teyi Pharmaceutical Group Co., Ltd. Compound Andrographis Paniculata Tablets Product Portfolio Table 160. Teyi Pharmaceutical Group Co., Ltd. Recent Development Table 161. Yunnan Dai Medicine Co., Ltd. Company Information Table 162. Yunnan Dai Medicine Co., Ltd. Business Overview Table 163. Yunnan Dai Medicine Co., Ltd. Compound Andrographis Paniculata Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 164. Yunnan Dai Medicine Co., Ltd. Compound Andrographis Paniculata Tablets Product Portfolio Table 165. Yunnan Dai Medicine Co., Ltd. Recent Development Table 166. Zhongshan Kekekang Pharmaceutical Co., Ltd. Company Information Table 167. Zhongshan Kekekang Pharmaceutical Co., Ltd. Business Overview Table 168. Zhongshan Kekekang Pharmaceutical Co., Ltd. Compound Andrographis Paniculata Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 169. Zhongshan Kekekang Pharmaceutical Co., Ltd. Compound Andrographis Paniculata Tablets Product Portfolio Table 170. Zhongshan Kekekang Pharmaceutical Co., Ltd. Recent Development Table 171. North America Compound Andrographis Paniculata Tablets Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 172. North America Compound Andrographis Paniculata Tablets Sales by Country (2021-2026) & (K Units) Table 173. North America Compound Andrographis Paniculata Tablets Sales Market Share by Country (2021-2026) Table 174. North America Compound Andrographis Paniculata Tablets Sales Forecast by Country (2027-2032) & (K Units) Table 175. North America Compound Andrographis Paniculata Tablets Sales Market Share Forecast by Country (2027-2032) Table 176. North America Compound Andrographis Paniculata Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 177. North America Compound Andrographis Paniculata Tablets Market Size by Country (2021-2026) & (US$ Million) Table 178. North America Compound Andrographis Paniculata Tablets Market Share by Country (2021-2026) Table 179. North America Compound Andrographis Paniculata Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 180. North America Compound Andrographis Paniculata Tablets Market Share Forecast by Country (2027-2032) Table 181. Europe Compound Andrographis Paniculata Tablets Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 182. Europe Compound Andrographis Paniculata Tablets Sales by Country (2021-2026) & (K Units) Table 183. Europe Compound Andrographis Paniculata Tablets Sales Market Share by Country (2021-2026) Table 184. Europe Compound Andrographis Paniculata Tablets Sales Forecast by Country (2027-2032) & (K Units) Table 185. Europe Compound Andrographis Paniculata Tablets Sales Market Share Forecast by Country (2027-2032) Table 186. Europe Compound Andrographis Paniculata Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 187. Europe Compound Andrographis Paniculata Tablets Market Size by Country (2021-2026) & (US$ Million) Table 188. Europe Compound Andrographis Paniculata Tablets Market Share by Country (2021-2026) Table 189. Europe Compound Andrographis Paniculata Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 190. Europe Compound Andrographis Paniculata Tablets Market Share Forecast by Country (2027-2032) Table 191. Asia-Pacific Compound Andrographis Paniculata Tablets Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 192. Asia-Pacific Compound Andrographis Paniculata Tablets Sales by Country (2021-2026) & (K Units) Table 193. Asia-Pacific Compound Andrographis Paniculata Tablets Sales Market Share by Country (2021-2026) Table 194. Asia-Pacific Compound Andrographis Paniculata Tablets Sales Forecast by Country (2027-2032) & (K Units) Table 195. Asia-Pacific Compound Andrographis Paniculata Tablets Sales Market Share Forecast by Country (2027-2032) Table 196. Asia-Pacific Compound Andrographis Paniculata Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 197. Asia-Pacific Compound Andrographis Paniculata Tablets Market Size by Country (2021-2026) & (US$ Million) Table 198. Asia-Pacific Compound Andrographis Paniculata Tablets Market Share by Country (2021-2026) Table 199. Asia-Pacific Compound Andrographis Paniculata Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 200. Asia-Pacific Compound Andrographis Paniculata Tablets Market Share Forecast by Country (2027-2032) Table 201. Latin America Compound Andrographis Paniculata Tablets Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 202. Latin America Compound Andrographis Paniculata Tablets Sales by Country (2021-2026) & (K Units) Table 203. Latin America Compound Andrographis Paniculata Tablets Sales Market Share by Country (2021-2026) Table 204. Latin America Compound Andrographis Paniculata Tablets Sales Forecast by Country (2027-2032) & (K Units) Table 205. Latin America Compound Andrographis Paniculata Tablets Sales Market Share Forecast by Country (2027-2032) Table 206. Latin America Compound Andrographis Paniculata Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 207. Latin America Compound Andrographis Paniculata Tablets Market Size by Country (2021-2026) & (US$ Million) Table 208. Latin America Compound Andrographis Paniculata Tablets Market Share by Country (2021-2026) Table 209. Latin America Compound Andrographis Paniculata Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 210. Latin America Compound Andrographis Paniculata Tablets Market Share Forecast by Country (2027-2032) Table 211. Middle East and Africa Compound Andrographis Paniculata Tablets Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 212. Middle East and Africa Compound Andrographis Paniculata Tablets Sales by Country (2021-2026) & (K Units) Table 213. Middle East and Africa Compound Andrographis Paniculata Tablets Sales Market Share by Country (2021-2026) Table 214. Middle East and Africa Compound Andrographis Paniculata Tablets Sales Forecast by Country (2027-2032) & (K Units) Table 215. Middle East and Africa Compound Andrographis Paniculata Tablets Sales Market Share Forecast by Country (2027-2032) Table 216. Middle East and Africa Compound Andrographis Paniculata Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 217. Middle East and Africa Compound Andrographis Paniculata Tablets Market Size by Country (2021-2026) & (US$ Million) Table 218. Middle East and Africa Compound Andrographis Paniculata Tablets Market Share by Country (2021-2026) Table 219. Middle East and Africa Compound Andrographis Paniculata Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 220. Middle East and Africa Compound Andrographis Paniculata Tablets Market Share Forecast by Country (2027-2032) Table 221. Key Raw Materials Table 222. Raw Materials Key Suppliers Table 223. Compound Andrographis Paniculata Tablets Distributors List Table 224. Compound Andrographis Paniculata Tablets Customers List Table 225. Research Programs/Design for This Report Table 226. Authors List of This Report Table 227. Secondary Sources Table 228. Primary Sources List of Figures Figure 1. Compound Andrographis Paniculata Tablets Image Figure 2. Global Compound Andrographis Paniculata Tablets Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Compound Andrographis Paniculata Tablets Market Size (2021-2032) & (US$ Million) Figure 4. Global Compound Andrographis Paniculata Tablets Sales (2021-2032) & (K Units) Figure 5. Film-coated Tablets Image Figure 6. Global Film-coated Tablets Sales YoY Growth (2021-2032) & (K Units) Figure 7. Sugar-coated Tablets Image Figure 8. Global Sugar-coated Tablets Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Compound Andrographis Paniculata Tablets Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Compound Andrographis Paniculata Tablets Market Share by Type 2025 VS 2032 Figure 11. North America Compound Andrographis Paniculata Tablets Sales Market Share in Volume by Type in 2025 Figure 12. North America Compound Andrographis Paniculata Tablets Sales Market Share in Value by Type in 2025 Figure 13. Europe Compound Andrographis Paniculata Tablets Sales Market Share in Volume by Type in 2025 Figure 14. Europe Compound Andrographis Paniculata Tablets Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Compound Andrographis Paniculata Tablets Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Compound Andrographis Paniculata Tablets Sales Market Share in Value by Type in 2025 Figure 17. Latin America Compound Andrographis Paniculata Tablets Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Compound Andrographis Paniculata Tablets Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Compound Andrographis Paniculata Tablets Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Compound Andrographis Paniculata Tablets Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Compound Andrographis Paniculata Tablets Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospital Image Figure 24. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 25. Clinic Image Figure 26. Global Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 27. Other Image Figure 28. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global Compound Andrographis Paniculata Tablets Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Compound Andrographis Paniculata Tablets Market Share by Application 2025 VS 2032 Figure 31. North America Compound Andrographis Paniculata Tablets Sales Market Share in Volume by Application in 2025 Figure 32. North America Compound Andrographis Paniculata Tablets Sales Market Share in Value by Application in 2025 Figure 33. Europe Compound Andrographis Paniculata Tablets Sales Market Share in Volume by Application in 2025 Figure 34. Europe Compound Andrographis Paniculata Tablets Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Compound Andrographis Paniculata Tablets Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Compound Andrographis Paniculata Tablets Sales Market Share in Value by Application in 2025 Figure 37. Latin America Compound Andrographis Paniculata Tablets Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Compound Andrographis Paniculata Tablets Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Compound Andrographis Paniculata Tablets Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Compound Andrographis Paniculata Tablets Sales Market Share in Value by Application in 2025 Figure 41. North America Compound Andrographis Paniculata Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America Compound Andrographis Paniculata Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Compound Andrographis Paniculata Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Compound Andrographis Paniculata Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Compound Andrographis Paniculata Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe Compound Andrographis Paniculata Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Compound Andrographis Paniculata Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Compound Andrographis Paniculata Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Compound Andrographis Paniculata Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific Compound Andrographis Paniculata Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Compound Andrographis Paniculata Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Compound Andrographis Paniculata Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Compound Andrographis Paniculata Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America Compound Andrographis Paniculata Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Compound Andrographis Paniculata Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Compound Andrographis Paniculata Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Compound Andrographis Paniculata Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa Compound Andrographis Paniculata Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Compound Andrographis Paniculata Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Compound Andrographis Paniculata Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Compound Andrographis Paniculata Tablets Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Compound Andrographis Paniculata Tablets Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Film-coated Tablets
  • Sugar-coated Tablets
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Baotou Traditional Chinese Medicine Co., Ltd.
  • Guangdong Hengcheng Pharmaceutical Co., Ltd.
  • Guangdong Huazhou Traditional Chinese Medicine Factory Pharmaceutical Co., Ltd.
  • Guangxi Beibu Gulf Pharmaceutical Co., Ltd.
  • Guangxi Chanfang Pharmaceutical Co., Ltd.
  • Guangxi Jinye Pharmaceutical Co., Ltd.
  • Hefei Cube Pharmaceutical Co., Ltd.
  • Henan Lingrui Pharmaceutical Co., Ltd.
  • Huizhou Daya Pharmaceutical Co., Ltd.
  • Leshi Tongren Sanmenxia Pharmaceutical Co., Ltd.
  • Luoyang Homeopathic Pharmaceutical Co., Ltd.
  • Sanmenxia Guangyu Biopharmaceutical Co., Ltd.
  • Sichuan Everbright Pharmaceutical Co., Ltd.
  • Sichuan Senke Pharmaceutical Co., Ltd.
  • Sichuan Tianji Biopharmaceutical Co., Ltd.
  • Sichuan Tongyuan Pharmaceutical Group Co., Ltd.
  • Sichuan Tiande Pharmaceutical Co., Ltd.
  • Teyi Pharmaceutical Group Co., Ltd.
  • Yunnan Dai Medicine Co., Ltd.
  • Zhongshan Kekekang Pharmaceutical Co., Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Compound Andrographis Paniculata Tablets Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Compound Andrographis Paniculata Tablets Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Compound Andrographis Paniculata Tablets Market by Type
  6. 1.3.1 Film-coated Tablets
  7. 1.3.2 Sugar-coated Tablets
  8. 1.4 Global Compound Andrographis Paniculata Tablets Market Size by Type
  9. 1.4.1 Global Compound Andrographis Paniculata Tablets Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Compound Andrographis Paniculata Tablets Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Compound Andrographis Paniculata Tablets Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Compound Andrographis Paniculata Tablets Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Compound Andrographis Paniculata Tablets Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Compound Andrographis Paniculata Tablets Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Compound Andrographis Paniculata Tablets Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Compound Andrographis Paniculata Tablets Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Compound Andrographis Paniculata Tablets Industry Trends
  2. 2.2 Compound Andrographis Paniculata Tablets Industry Drivers
  3. 2.3 Compound Andrographis Paniculata Tablets Industry Opportunities and Challenges
  4. 2.4 Compound Andrographis Paniculata Tablets Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Compound Andrographis Paniculata Tablets Revenue (2021-2026)
  2. 3.2 Global Top Players by Compound Andrographis Paniculata Tablets Sales (2021-2026)
  3. 3.3 Global Top Players by Compound Andrographis Paniculata Tablets Price (2021-2026)
  4. 3.4 Global Compound Andrographis Paniculata Tablets Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Compound Andrographis Paniculata Tablets Major Company Production Sites & Headquarters
  6. 3.6 Global Compound Andrographis Paniculata Tablets Company, Product Type & Application
  7. 3.7 Global Compound Andrographis Paniculata Tablets Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Compound Andrographis Paniculata Tablets Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Compound Andrographis Paniculata Tablets Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Compound Andrographis Paniculata Tablets Tier 1, Tier 2, and Tier 3
4 Compound Andrographis Paniculata Tablets Regional Status and Outlook
  1. 4.1 Global Compound Andrographis Paniculata Tablets Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Compound Andrographis Paniculata Tablets Historic Market Size by Region
  3. 4.2.1 Global Compound Andrographis Paniculata Tablets Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Compound Andrographis Paniculata Tablets Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Compound Andrographis Paniculata Tablets Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Compound Andrographis Paniculata Tablets Forecasted Market Size by Region
  7. 4.3.1 Global Compound Andrographis Paniculata Tablets Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Compound Andrographis Paniculata Tablets Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Compound Andrographis Paniculata Tablets Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Compound Andrographis Paniculata Tablets by Application
  1. 5.1 Compound Andrographis Paniculata Tablets Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Other
  5. 5.2 Global Compound Andrographis Paniculata Tablets Market Size by Application
  6. 5.2.1 Global Compound Andrographis Paniculata Tablets Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Compound Andrographis Paniculata Tablets Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Compound Andrographis Paniculata Tablets Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Compound Andrographis Paniculata Tablets Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Compound Andrographis Paniculata Tablets Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Compound Andrographis Paniculata Tablets Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Compound Andrographis Paniculata Tablets Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Compound Andrographis Paniculata Tablets Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Baotou Traditional Chinese Medicine Co., Ltd.
  2. 6.1.1 Baotou Traditional Chinese Medicine Co., Ltd. Company Information
  3. 6.1.2 Baotou Traditional Chinese Medicine Co., Ltd. Business Overview
  4. 6.1.3 Baotou Traditional Chinese Medicine Co., Ltd. Compound Andrographis Paniculata Tablets Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Baotou Traditional Chinese Medicine Co., Ltd. Compound Andrographis Paniculata Tablets Product Portfolio
  6. 6.1.5 Baotou Traditional Chinese Medicine Co., Ltd. Recent Developments
  7. 6.2 Guangdong Hengcheng Pharmaceutical Co., Ltd.
  8. 6.2.1 Guangdong Hengcheng Pharmaceutical Co., Ltd. Company Information
  9. 6.2.2 Guangdong Hengcheng Pharmaceutical Co., Ltd. Business Overview
  10. 6.2.3 Guangdong Hengcheng Pharmaceutical Co., Ltd. Compound Andrographis Paniculata Tablets Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Guangdong Hengcheng Pharmaceutical Co., Ltd. Compound Andrographis Paniculata Tablets Product Portfolio
  12. 6.2.5 Guangdong Hengcheng Pharmaceutical Co., Ltd. Recent Developments
  13. 6.3 Guangdong Huazhou Traditional Chinese Medicine Factory Pharmaceutical Co., Ltd.
  14. 6.3.1 Guangdong Huazhou Traditional Chinese Medicine Factory Pharmaceutical Co., Ltd. Company Information
  15. 6.3.2 Guangdong Huazhou Traditional Chinese Medicine Factory Pharmaceutical Co., Ltd. Business Overview
  16. 6.3.3 Guangdong Huazhou Traditional Chinese Medicine Factory Pharmaceutical Co., Ltd. Compound Andrographis Paniculata Tablets Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Guangdong Huazhou Traditional Chinese Medicine Factory Pharmaceutical Co., Ltd. Compound Andrographis Paniculata Tablets Product Portfolio
  18. 6.3.5 Guangdong Huazhou Traditional Chinese Medicine Factory Pharmaceutical Co., Ltd. Recent Developments
  19. 6.4 Guangxi Beibu Gulf Pharmaceutical Co., Ltd.
  20. 6.4.1 Guangxi Beibu Gulf Pharmaceutical Co., Ltd. Company Information
  21. 6.4.2 Guangxi Beibu Gulf Pharmaceutical Co., Ltd. Business Overview
  22. 6.4.3 Guangxi Beibu Gulf Pharmaceutical Co., Ltd. Compound Andrographis Paniculata Tablets Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Guangxi Beibu Gulf Pharmaceutical Co., Ltd. Compound Andrographis Paniculata Tablets Product Portfolio
  24. 6.4.5 Guangxi Beibu Gulf Pharmaceutical Co., Ltd. Recent Developments
  25. 6.5 Guangxi Chanfang Pharmaceutical Co., Ltd.
  26. 6.5.1 Guangxi Chanfang Pharmaceutical Co., Ltd. Company Information
  27. 6.5.2 Guangxi Chanfang Pharmaceutical Co., Ltd. Business Overview
  28. 6.5.3 Guangxi Chanfang Pharmaceutical Co., Ltd. Compound Andrographis Paniculata Tablets Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Guangxi Chanfang Pharmaceutical Co., Ltd. Compound Andrographis Paniculata Tablets Product Portfolio
  30. 6.5.5 Guangxi Chanfang Pharmaceutical Co., Ltd. Recent Developments
  31. 6.6 Guangxi Jinye Pharmaceutical Co., Ltd.
  32. 6.6.1 Guangxi Jinye Pharmaceutical Co., Ltd. Company Information
  33. 6.6.2 Guangxi Jinye Pharmaceutical Co., Ltd. Business Overview
  34. 6.6.3 Guangxi Jinye Pharmaceutical Co., Ltd. Compound Andrographis Paniculata Tablets Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Guangxi Jinye Pharmaceutical Co., Ltd. Compound Andrographis Paniculata Tablets Product Portfolio
  36. 6.6.5 Guangxi Jinye Pharmaceutical Co., Ltd. Recent Developments
  37. 6.7 Hefei Cube Pharmaceutical Co., Ltd.
  38. 6.7.1 Hefei Cube Pharmaceutical Co., Ltd. Company Information
  39. 6.7.2 Hefei Cube Pharmaceutical Co., Ltd. Business Overview
  40. 6.7.3 Hefei Cube Pharmaceutical Co., Ltd. Compound Andrographis Paniculata Tablets Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Hefei Cube Pharmaceutical Co., Ltd. Compound Andrographis Paniculata Tablets Product Portfolio
  42. 6.7.5 Hefei Cube Pharmaceutical Co., Ltd. Recent Developments
  43. 6.8 Henan Lingrui Pharmaceutical Co., Ltd.
  44. 6.8.1 Henan Lingrui Pharmaceutical Co., Ltd. Company Information
  45. 6.8.2 Henan Lingrui Pharmaceutical Co., Ltd. Business Overview
  46. 6.8.3 Henan Lingrui Pharmaceutical Co., Ltd. Compound Andrographis Paniculata Tablets Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Henan Lingrui Pharmaceutical Co., Ltd. Compound Andrographis Paniculata Tablets Product Portfolio
  48. 6.8.5 Henan Lingrui Pharmaceutical Co., Ltd. Recent Developments
  49. 6.9 Huizhou Daya Pharmaceutical Co., Ltd.
  50. 6.9.1 Huizhou Daya Pharmaceutical Co., Ltd. Company Information
  51. 6.9.2 Huizhou Daya Pharmaceutical Co., Ltd. Business Overview
  52. 6.9.3 Huizhou Daya Pharmaceutical Co., Ltd. Compound Andrographis Paniculata Tablets Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Huizhou Daya Pharmaceutical Co., Ltd. Compound Andrographis Paniculata Tablets Product Portfolio
  54. 6.9.5 Huizhou Daya Pharmaceutical Co., Ltd. Recent Developments
  55. 6.10 Leshi Tongren Sanmenxia Pharmaceutical Co., Ltd.
  56. 6.10.1 Leshi Tongren Sanmenxia Pharmaceutical Co., Ltd. Company Information
  57. 6.10.2 Leshi Tongren Sanmenxia Pharmaceutical Co., Ltd. Business Overview
  58. 6.10.3 Leshi Tongren Sanmenxia Pharmaceutical Co., Ltd. Compound Andrographis Paniculata Tablets Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Leshi Tongren Sanmenxia Pharmaceutical Co., Ltd. Compound Andrographis Paniculata Tablets Product Portfolio
  60. 6.10.5 Leshi Tongren Sanmenxia Pharmaceutical Co., Ltd. Recent Developments
  61. 6.11 Luoyang Homeopathic Pharmaceutical Co., Ltd.
  62. 6.11.1 Luoyang Homeopathic Pharmaceutical Co., Ltd. Company Information
  63. 6.11.2 Luoyang Homeopathic Pharmaceutical Co., Ltd. Business Overview
  64. 6.11.3 Luoyang Homeopathic Pharmaceutical Co., Ltd. Compound Andrographis Paniculata Tablets Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Luoyang Homeopathic Pharmaceutical Co., Ltd. Compound Andrographis Paniculata Tablets Product Portfolio
  66. 6.11.5 Luoyang Homeopathic Pharmaceutical Co., Ltd. Recent Developments
  67. 6.12 Sanmenxia Guangyu Biopharmaceutical Co., Ltd.
  68. 6.12.1 Sanmenxia Guangyu Biopharmaceutical Co., Ltd. Company Information
  69. 6.12.2 Sanmenxia Guangyu Biopharmaceutical Co., Ltd. Business Overview
  70. 6.12.3 Sanmenxia Guangyu Biopharmaceutical Co., Ltd. Compound Andrographis Paniculata Tablets Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Sanmenxia Guangyu Biopharmaceutical Co., Ltd. Compound Andrographis Paniculata Tablets Product Portfolio
  72. 6.12.5 Sanmenxia Guangyu Biopharmaceutical Co., Ltd. Recent Developments
  73. 6.13 Sichuan Everbright Pharmaceutical Co., Ltd.
  74. 6.13.1 Sichuan Everbright Pharmaceutical Co., Ltd. Company Information
  75. 6.13.2 Sichuan Everbright Pharmaceutical Co., Ltd. Business Overview
  76. 6.13.3 Sichuan Everbright Pharmaceutical Co., Ltd. Compound Andrographis Paniculata Tablets Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Sichuan Everbright Pharmaceutical Co., Ltd. Compound Andrographis Paniculata Tablets Product Portfolio
  78. 6.13.5 Sichuan Everbright Pharmaceutical Co., Ltd. Recent Developments
  79. 6.14 Sichuan Senke Pharmaceutical Co., Ltd.
  80. 6.14.1 Sichuan Senke Pharmaceutical Co., Ltd. Company Information
  81. 6.14.2 Sichuan Senke Pharmaceutical Co., Ltd. Business Overview
  82. 6.14.3 Sichuan Senke Pharmaceutical Co., Ltd. Compound Andrographis Paniculata Tablets Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Sichuan Senke Pharmaceutical Co., Ltd. Compound Andrographis Paniculata Tablets Product Portfolio
  84. 6.14.5 Sichuan Senke Pharmaceutical Co., Ltd. Recent Developments
  85. 6.15 Sichuan Tianji Biopharmaceutical Co., Ltd.
  86. 6.15.1 Sichuan Tianji Biopharmaceutical Co., Ltd. Company Information
  87. 6.15.2 Sichuan Tianji Biopharmaceutical Co., Ltd. Business Overview
  88. 6.15.3 Sichuan Tianji Biopharmaceutical Co., Ltd. Compound Andrographis Paniculata Tablets Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Sichuan Tianji Biopharmaceutical Co., Ltd. Compound Andrographis Paniculata Tablets Product Portfolio
  90. 6.15.5 Sichuan Tianji Biopharmaceutical Co., Ltd. Recent Developments
  91. 6.16 Sichuan Tongyuan Pharmaceutical Group Co., Ltd.
  92. 6.16.1 Sichuan Tongyuan Pharmaceutical Group Co., Ltd. Company Information
  93. 6.16.2 Sichuan Tongyuan Pharmaceutical Group Co., Ltd. Business Overview
  94. 6.16.3 Sichuan Tongyuan Pharmaceutical Group Co., Ltd. Compound Andrographis Paniculata Tablets Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Sichuan Tongyuan Pharmaceutical Group Co., Ltd. Compound Andrographis Paniculata Tablets Product Portfolio
  96. 6.16.5 Sichuan Tongyuan Pharmaceutical Group Co., Ltd. Recent Developments
  97. 6.17 Sichuan Tiande Pharmaceutical Co., Ltd.
  98. 6.17.1 Sichuan Tiande Pharmaceutical Co., Ltd. Company Information
  99. 6.17.2 Sichuan Tiande Pharmaceutical Co., Ltd. Business Overview
  100. 6.17.3 Sichuan Tiande Pharmaceutical Co., Ltd. Compound Andrographis Paniculata Tablets Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 Sichuan Tiande Pharmaceutical Co., Ltd. Compound Andrographis Paniculata Tablets Product Portfolio
  102. 6.17.5 Sichuan Tiande Pharmaceutical Co., Ltd. Recent Developments
  103. 6.18 Teyi Pharmaceutical Group Co., Ltd.
  104. 6.18.1 Teyi Pharmaceutical Group Co., Ltd. Company Information
  105. 6.18.2 Teyi Pharmaceutical Group Co., Ltd. Business Overview
  106. 6.18.3 Teyi Pharmaceutical Group Co., Ltd. Compound Andrographis Paniculata Tablets Sales, Revenue and Gross Margin (2021-2026)
  107. 6.18.4 Teyi Pharmaceutical Group Co., Ltd. Compound Andrographis Paniculata Tablets Product Portfolio
  108. 6.18.5 Teyi Pharmaceutical Group Co., Ltd. Recent Developments
  109. 6.19 Yunnan Dai Medicine Co., Ltd.
  110. 6.19.1 Yunnan Dai Medicine Co., Ltd. Company Information
  111. 6.19.2 Yunnan Dai Medicine Co., Ltd. Business Overview
  112. 6.19.3 Yunnan Dai Medicine Co., Ltd. Compound Andrographis Paniculata Tablets Sales, Revenue and Gross Margin (2021-2026)
  113. 6.19.4 Yunnan Dai Medicine Co., Ltd. Compound Andrographis Paniculata Tablets Product Portfolio
  114. 6.19.5 Yunnan Dai Medicine Co., Ltd. Recent Developments
  115. 6.20 Zhongshan Kekekang Pharmaceutical Co., Ltd.
  116. 6.20.1 Zhongshan Kekekang Pharmaceutical Co., Ltd. Company Information
  117. 6.20.2 Zhongshan Kekekang Pharmaceutical Co., Ltd. Business Overview
  118. 6.20.3 Zhongshan Kekekang Pharmaceutical Co., Ltd. Compound Andrographis Paniculata Tablets Sales, Revenue and Gross Margin (2021-2026)
  119. 6.20.4 Zhongshan Kekekang Pharmaceutical Co., Ltd. Compound Andrographis Paniculata Tablets Product Portfolio
  120. 6.20.5 Zhongshan Kekekang Pharmaceutical Co., Ltd. Recent Developments
7 North America by Country
  1. 7.1 North America Compound Andrographis Paniculata Tablets Sales by Country
  2. 7.1.1 North America Compound Andrographis Paniculata Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Compound Andrographis Paniculata Tablets Sales by Country (2021-2026)
  4. 7.1.3 North America Compound Andrographis Paniculata Tablets Sales Forecast by Country (2027-2032)
  5. 7.2 North America Compound Andrographis Paniculata Tablets Market Size by Country
  6. 7.2.1 North America Compound Andrographis Paniculata Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Compound Andrographis Paniculata Tablets Market Size by Country (2021-2026)
  8. 7.2.3 North America Compound Andrographis Paniculata Tablets Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Compound Andrographis Paniculata Tablets Sales by Country
  2. 8.1.1 Europe Compound Andrographis Paniculata Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Compound Andrographis Paniculata Tablets Sales by Country (2021-2026)
  4. 8.1.3 Europe Compound Andrographis Paniculata Tablets Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Compound Andrographis Paniculata Tablets Market Size by Country
  6. 8.2.1 Europe Compound Andrographis Paniculata Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Compound Andrographis Paniculata Tablets Market Size by Country (2021-2026)
  8. 8.2.3 Europe Compound Andrographis Paniculata Tablets Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Compound Andrographis Paniculata Tablets Sales by Country
  2. 9.1.1 Asia-Pacific Compound Andrographis Paniculata Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Compound Andrographis Paniculata Tablets Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Compound Andrographis Paniculata Tablets Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Compound Andrographis Paniculata Tablets Market Size by Country
  6. 9.2.1 Asia-Pacific Compound Andrographis Paniculata Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Compound Andrographis Paniculata Tablets Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Compound Andrographis Paniculata Tablets Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Compound Andrographis Paniculata Tablets Sales by Country
  2. 10.1.1 South America Compound Andrographis Paniculata Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Compound Andrographis Paniculata Tablets Sales by Country (2021-2026)
  4. 10.1.3 South America Compound Andrographis Paniculata Tablets Sales Forecast by Country (2027-2032)
  5. 10.2 South America Compound Andrographis Paniculata Tablets Market Size by Country
  6. 10.2.1 South America Compound Andrographis Paniculata Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Compound Andrographis Paniculata Tablets Market Size by Country (2021-2026)
  8. 10.2.3 South America Compound Andrographis Paniculata Tablets Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Compound Andrographis Paniculata Tablets Sales by Country
  2. 11.1.1 Middle East and Africa Compound Andrographis Paniculata Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Compound Andrographis Paniculata Tablets Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Compound Andrographis Paniculata Tablets Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Compound Andrographis Paniculata Tablets Market Size by Country
  6. 11.2.1 Middle East and Africa Compound Andrographis Paniculata Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Compound Andrographis Paniculata Tablets Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Compound Andrographis Paniculata Tablets Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Compound Andrographis Paniculata Tablets Value Chain Analysis
  2. 12.1.1 Compound Andrographis Paniculata Tablets Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Compound Andrographis Paniculata Tablets Production Mode & Process
  7. 12.2 Compound Andrographis Paniculata Tablets Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Compound Andrographis Paniculata Tablets Distributors
  10. 12.2.3 Compound Andrographis Paniculata Tablets Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst